These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9838938)

  • 1. Psychological distress in blood donors notified of HTLV-I/II infection. Retrovirus Epidemiology Donor Study.
    Guiltinan AM; Murphy EL; Horton JA; Nass CC; McEntire RL; Watanabe K
    Transfusion; 1998; 38(11-12):1056-62. PubMed ID: 9838938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major depression and generalized anxiety disorder among human T-lymphotropic virus types I- and II-infected former blood donors.
    Guiltinan AM; Kaidarova Z; Behan D; Marosi C; Hutching S; Kaiser M; Moore E; Devita D; Murphy EL;
    Transfusion; 2013 Jan; 53(1):60-8. PubMed ID: 22554308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased incidence of infectious diseases during prospective follow-up of human T-lymphotropic virus type II- and I-infected blood donors. Retrovirus Epidemiology Donor Study.
    Murphy EL; Glynn SA; Fridey J; Smith JW; Sacher RA; Nass CC; Ownby HE; Wright DJ; Nemo GJ
    Arch Intern Med; 1999 Jul; 159(13):1485-91. PubMed ID: 10399901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of the understanding of blood donors with human T-cell leukaemia virus type 1 using a new information booklet.
    Nakamura H; Sagara Y; Yamamoto M; Utsunomiya A; Watanabe T; Satake M; Irita K
    Transfus Med; 2021 Dec; 31(6):481-487. PubMed ID: 34549482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transmission of retroviruses from seronegative donors by transfusion during cardiac surgery. A multicenter study of HIV-1 and HTLV-I/II infections.
    Nelson KE; Donahue JG; Muñoz A; Cohen ND; Ness PM; Teague A; Stambolis VA; Yawn DH; Callicott B; McAllister H
    Ann Intern Med; 1992 Oct; 117(7):554-9. PubMed ID: 1524329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for human T-cell lymphotropic virus types I and II (HTLV-I and -II) in blood donors: the Retrovirus Epidemiology Donor Study. NHLBI Retrovirus Epidemiology Donor Study.
    Schreiber GB; Murphy EL; Horton JA; Wright DJ; Garfein R; Chien HC; Nass CC
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Mar; 14(3):263-71. PubMed ID: 9117460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory test differences associated with HTLV-I and HTLV-II infection. Retrovirus Epidemiology Donor Study Investigators.
    Murphy EL; Glynn S; Watanabe K; Fridey J; Smith J; Sacher R; Wright D; Schreiber G; Luban N
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr; 17(4):332-8. PubMed ID: 9525434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil.
    Segurado AA; Malaque CM; Sumita LM; Pannuti CS; Lal RB
    Am J Trop Med Hyg; 1997 Aug; 57(2):142-8. PubMed ID: 9288805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Seropositivity for human T-lymphotropic virus types I and II among donors at the Municipal Blood Bank of Caracas and associated risk factors].
    León G; Quirós AM; López JL; Hung M; Díaz AM; Goncalves J; Da Costa O; Hernández T; Chirinos M; Gómez R
    Rev Panam Salud Publica; 2003; 13(2-3):117-23. PubMed ID: 12744787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence among blood donors for a 30-year-old epidemic of human T lymphotropic virus type II infection in the United States.
    Murphy EL; Watanabe K; Nass CC; Ownby H; Williams A; Nemo G
    J Infect Dis; 1999 Dec; 180(6):1777-83. PubMed ID: 10558931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of evidence of infection with divergent primate T-lymphotropic viruses in United States blood donors who have seroindeterminate HTLV test results.
    Busch MP; Switzer WM; Murphy EL; Thomson R; Heneine W
    Transfusion; 2000 Apr; 40(4):443-9. PubMed ID: 10773057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative prevalence and risk factors of HTLV-I and HTLV-II infection in US blood donors.
    Lee HH; Swanson P; Rosenblatt JD; Chen IS; Sherwood WC; Smith DE; Tegtmeier GE; Fernando LP; Fang CT; Osame M
    Lancet; 1991 Jun; 337(8755):1435-9. PubMed ID: 1675317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased prevalence of infectious diseases and other adverse outcomes in human T lymphotropic virus types I- and II-infected blood donors. Retrovirus Epidemiology Donor Study (REDS) Study Group.
    Murphy EL; Glynn SA; Fridey J; Sacher RA; Smith JW; Wright DJ; Newman B; Gibble JW; Ameti DI; Nass CC; Schreiber GB; Nemo GJ
    J Infect Dis; 1997 Dec; 176(6):1468-75. PubMed ID: 9395356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The epidemiology of human T-cell lymphotropic virus types I and II in Canadian blood donors.
    O'Brien SF; Goldman M; Scalia V; Yi QL; Fan W; Xi G; Dines IR; Fearon MA
    Transfus Med; 2013 Oct; 23(5):358-66. PubMed ID: 23859527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HTLV-I/II and blood donors: determinants associated with seropositivity in a low risk population.
    Soares BC; Proietti AB; Proietti FA;
    Rev Saude Publica; 2003 Aug; 37(4):470-6. PubMed ID: 12937708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
    Blejer JL; Saguier MC; Salamone HJ; Carreras LA
    Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human T-Lymphotropic Virus Type 1 and 2 Seroprevalence among first-time blood donors in Chile, 2011-2013.
    San Martín H; Balanda M; Vergara N; Valenzuela MA; Cartier L; Ayala S; Ramírez E
    J Med Virol; 2016 Jun; 88(6):1067-75. PubMed ID: 26538335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular epidemiology of HTLV-II among United States blood donors and intravenous drug users: an age-cohort effect for HTLV-II RFLP type aO.
    Murphy EL; Mahieux R; de Thé G; Tekaia F; Ameti D; Horton J; Gessain A
    Virology; 1998 Mar; 242(2):425-34. PubMed ID: 9514966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human T-lymphotropic virus (HTLV) types I and II infection in sexual contacts and family members of blood donors who are seropositive for HTLV type I or II. American Red Cross HTLV-I/II Collaborative Study Group.
    Sullivan MT; Williams AE; Fang CT; Notari EP; Poiesz BJ; Ehrlich GD
    Transfusion; 1993 Jul; 33(7):585-90. PubMed ID: 8333022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence and geographical distribution of human T-lymphotropic virus type 1 among volunteer blood donors in endemic areas of Iran.
    Karimi G; Zadsar M; Pourfathollah AA
    Virol J; 2017 Jan; 14(1):14. PubMed ID: 28137274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.